Diabetes Mellitus, Type 2: all 9,589 studies
Page 92 of 96. Open to participants first (1,332), then studies with results posted, then the rest; newest registration first within each.
- Evaluation of Effect of Exercise on PrescriptionStatus unknownNCT00399997Phase 2/3
- A Trial Comparing Lantus Algorithms to Achieve Normal Blood Glucose Targets in Subjects With Uncontrolled Blood Sugar With Type 2 Diabetes MellitusCompletedNCT00399724Phase 4
- Effect of Repaglinide and Metformin Combination Tablet or Rosiglitazone and Metformin in Fixed Dose Combination on Blood Glucose Control in Patients With Type 2 DiabetesCompletedNCT00399711Phase 3
- Comparison of Cardiovascular Outcomes of Pioglitazone and Metformin in Type 2 Diabetes PatientsWithdrawnNCT00399204Phase 4
- The Effects of Lipoic Acid on Glycaemic Control in Type 2 DiabetesWithdrawnNCT00398892Phase 2
- Effect of Chromium Picolinate on Insulin Sensitivity in Type 2 DiabetesCompletedNCT00398853Phase 4
- GOAL Life-Style Change Intervention to Prevent Type 2 DiabetesCompletedNCT00398060Phase 3
- Double Blind Randomized Trial to Compare Gurmar (Gymnema Sylvestre) With Metformin in Type 2 DiabetesStatus unknownNCT00396851Not applicable
- Efficacy/Safety of Vildagliptin and Metformin Combination Therapy in Patients With Type 2 Diabetes Not Well Controlled With Metformin AloneCompletedNCT00396357Phase 3
- Safety and Efficacy of Vildagliptin vs. Thiazolidinedione as add-on Therapy to Metformin in Patients With Type 2 Diabetes Not Controlled With Metformin AloneCompletedNCT00396227Phase 3
- Efficacy and Safety of Vildagliptin Compared to Placebo on the Incretin Effect in Patients With Type 2 Diabetes Treated With MetforminCompletedNCT00396071Phase 3
- The Diabetes Specialist Nurse as Delegated Main Care Provider for Patients With Type 2 DiabetesCompletedNCT00394875Not applicable
- Injection Site Study In Patients With Type 2 Diabetes Mellitus (T2DM) And Healthy VolunteersCompletedNCT00394030Phase 1
- Acetylcarnitine and Insulin SensitivityCompletedNCT00393770Phase 2
- Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes MellitusCompletedNCT00391209Phase 3
- Efficacy and Safety of Vildagliptin Versus Placebo in Patients With Type 2 DiabetesCompletedNCT00390520Phase 3
- Long Term Safety of Vildagliptin (100mg qd) In Patients With Type 2 DiabetesCompletedNCT00389415Phase 3
- A Drug-Drug Interaction Study of GK Activator (2) and Glyburide in Patients With Type 2 Diabetes.CompletedNCT00388986Phase 1
- A Study of Aleglitazar in Patients With Type 2 DiabetesCompletedNCT00388518Phase 2
- Study Of Denagliptin In Subjects With Type 2 Diabetes Mellitus (T2DM)WithdrawnNCT00387972Phase 2/3
- Exercise and Cardiovascular Control During Upright Tilt in Older Adults With Type 2 DiabetesCompletedNCT00387452Not applicable
- Insulin Glargine [rDNA Origin] Injection vs Pioglitazone as add-on Therapy in Patients Failing Monotherapy With Sulfonylurea or MetforminCompletedNCT00384215Phase 4
- Effect of Insulin Detemir on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00383877Phase 3
- Efficacy and Safety of Vildagliptin Compared to Metformin in Elderly Drug Naive Patients With Type 2 DiabetesCompletedNCT00383578Phase 3
- Mitochondrial Dysfunction in Type 2 Diabetes Mellitus and Capacity for Fat Oxidation During ExerciseTerminatedNCT00382473Not applicable
- A Study to Assess the Effect on Glucose Control and Safety and Tolerability of LY2148568 In Japanese Patients With Type 2 DiabetesCompletedNCT00382239Phase 2
- Efficacy of Fixed Combination Therapy of Vildagliptin and Metformin Compared to the Individual Monotherapy Components in Drug Naive Patients With Type 2 DiabetesCompletedNCT00382096Phase 3
- Safety and Efficacy of Exenatide as MonotherapyCompletedNCT00381342Phase 3
- Impact of 3-year Lifestyle Intervention on Postprandial Glucose Metabolism: the SLIM StudyCompletedNCT00381186Not applicable
- Double-Blind Study of Miglitol in Japanese With type2 DiabetesCompletedNCT00380822Phase 3
- Effect of Vildagliptin on Fat and Muscle Metabolism in Patients With Type 2 DiabetesCompletedNCT00380445Phase 3
- A Study to Assess the Acute Effects of Vildagliptin on Gastric Emptying in Patients With Type 2 Diabetes.CompletedNCT00380380Phase 3
- Study of Improving Insulin Sensitivity by Electroacupuncture TherapyCompletedNCT00379379Not applicable
- A Drug-Drug Interaction Study of GK Activator (2) and Simvastatin in Patients With Type 2 Diabetes.CompletedNCT00377442Phase 1
- Efficacy, Safety and Tolerability of Pioglitazone-Azilsartan in Subjects With Type 2 Diabetes MellitusTerminatedNCT00376181Phase 3
- Drug Interactions From Simultaneous Administration Of Metformin And GSK189075 To Subjects With Type 2 DiabetesCompletedNCT00376038Phase 1
- The HOME Trial: Hyperinsulinaemia: the Outcome of Its Metabolic Effects, a Randomized Controlled TrialCompletedNCT00375388Phase 3
- Study of the Relationship Between Blood Vessels and Insulin Response in AdolescentsCompletedNCT00374361
- Improving Blood Pressure Management in Patients With DiabetesCompletedNCT00374270Phase 4
- Metabolic Effects of Treatment in Patients With Recently Diagnosed Type 2 DiabetesCompletedNCT00373178Phase 4
- Internet Diabetes Self-ManagementCompletedNCT00372463Phase 2
- MK-0431 Early Phase II Double-blind Study - Type 2 Diabetes Mellitus (0431-043)CompletedNCT00371007Phase 2
- GW823093C For The Treatment Of Type 2 Diabetes MellitusTerminatedNCT00370942Phase 2
- Effect on Glycemic Control of Inhaled Insulin Alone or Added to Dual Oral Therapy After Failure of Dual Oral Therapy.CompletedNCT00370565Phase 3
- A Study of the Effect of Renal Impairment on the Activity of GK Activator (2) in Patients With Type 2 Diabetes.CompletedNCT00368368Phase 1
- To Compare the Efficacy and Safey of Vildagliptin Compared to Voglibose in Patients With Type 2 DiabetesCompletedNCT00368134Phase 3
- A Clinical Trial Comparing Short-Term Efficacy and Safety of Exubera and LantusCompletedNCT00367445Phase 4
- A Dose-Titration Study of GK Activator (2) in Patients With Type 2 Diabetes.CompletedNCT00366379Phase 2
- Examination of Dermatologic Effects From Subcutaneous Injections of ISIS 113715CompletedNCT00365781Phase 1
- Influence of Physical Training on Mitochondrial Function in Type 2 Diabetic PatientsStatus unknownNCT00365495Not applicable
- Moderate Alcohol Consumption, Fat and Carbohydrate Metabolism and Insulin SensitivityCompletedNCT00364767Not applicable
- Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes MellitusCompletedNCT00363948Phase 3
- Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes MellitusCompletedNCT00363844Phase 3
- Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes MellitusCompletedNCT00363519Phase 3
- The Potential Effects and Mechanisms of Flax Lignans on Type 2 Diabetes MellitusCompletedNCT00363233Phase 2/3
- Olmesartan Medoxomil and Diabetic NephropathyCompletedNCT00362960Phase 3
- Fenofibrate and Metformin Insulin Sensitivity in Type 2 Diabetics StudyTerminatedNCT00362765Phase 2/3
- Effect of Chia Seeds (Salvia Hispanica L.) on Glucose Control in Patients With Type 2 DiabetesCompletedNCT00362011Phase 2
- The Role of Amylin and Incretins on Postprandial Metabolisms in Adolescents With Type 2 Diabetes Mellitus (T2DM).CompletedNCT00361946
- Dose-Ranging Study Evaluating AVE2268 in Patients With Type 2 Diabetes Not Adequately Controlled by a Metformin TreatmentCompletedNCT00361738Phase 2
- Effects on Colesevelam HC1 (WelChol®) on Insulin Sensitivity in Subjects With Type 2 Diabetes MellitusCompletedNCT00361153Phase 2
- Effects of Losartan on Insulin Sensitivity and Secretion in Type 2 Diabetes and NephropathyCompletedNCT00361023Not applicable
- Comparison of Exenatide Taken Before Lunch and Dinner With Before Breakfast and Dinner in Patients With Type 2 DiabetesCompletedNCT00359879Phase 3
- AVANDAMET Versus Metformin And Sulphonylurea In People With Poorly Controlled Type 2 DiabetesCompletedNCT00359112Phase 3
- Noninvasive Skin Spectroscopy for Diabetes ScreeningCompletedNCT00358254
- Insulin Glargine v Rosiglitazone as add-on Therapy in Patients Failing Sulfonylurea and Metformin Combination TherapyCompletedNCT00358124Phase 4
- Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 DiabetesCompletedNCT00355849Phase 3
- Insulin Analogue With Continuous Glucose Monitoring System (CGMS) MeasurementCompletedNCT00354939Phase 4
- In-patient Study With GSK716155 In Patients With Type 2 Diabetes MellitusCompletedNCT00354536Phase 2
- DARE: Diabetes in cArdiac REhabilitationCompletedNCT00354237Not applicable
- Glimepiride vs Metformin as Monotherapy in Pediatric Subjects With Type 2 Diabetes MellitusCompletedNCT00353691Phase 3
- Safety and Efficacy Study of Metaglidasen in Type 2 Diabetes in Patients Suboptimally Controlled on InsulinCompletedNCT00353587Phase 2/3
- Efficacy of Vildagliptin 100 MG as Compared to Placebo as Add-on to Metformin in Patients With Type 2 DiabetesCompletedNCT00351884Phase 3
- A Study To Compare the Effect of Vildagliptin Compared to Placebo in Patients With Type 2 DiabetesCompletedNCT00351832Phase 3
- Capturing Outcomes of Clinical Activities Performed by a Rounding Pharmacist Practising in a Team EnvironmentCompletedNCT00351676Phase 4
- A Study to Evaluate the Effect of Vildagliptin on the Maximum Insulin Secretion in Patients With Type 2 DiabetesCompletedNCT00351585Phase 3
- A Study to Assess the Effects of DPP-4 Inhibition on Insulin Sensitivity in Type 2 DiabetesCompletedNCT00351546Phase 3
- A Study to Assess the Effects of Vildagliptin on Gastric Emptying in Patients With Type 2 DiabetesCompletedNCT00351507Phase 3
- LANTUSTITR: Insulin Glargine in Type 2 Diabetes MellitusTerminatedNCT00349986Phase 4
- A Study Of Rosiglitazone Plus Insulin To Treat Type 2 Diabetes Mellitus PatientsCompletedNCT00349427Phase 3
- Efficacy and Safety of Inhaled Pre-prandial Human Insulin in Type 2 DiabetesTerminatedNCT00348712Phase 3
- Jikei Optimal Insulin Therapy in Type 2 DiabetesStatus unknownNCT00348231Not applicable
- A Trial to Study the Effect of Vitamin D Supplementation on Glucose and Insulin Metabolism in Centrally Obese MenCompletedNCT00347542Not applicable
- Insulin Glargine in Type 2 Diabetic PatientsCompletedNCT00347100Phase 4
- Exercise and Activity Guidance in Older Adults With DiabetesCompletedNCT00344240Not applicable
- Safety and Efficacy of Inhaled Pre-prandial Human Insulin in Type 2 DiabetesTerminatedNCT00343980Phase 3
- Comparison of NovoFine® Needles (4 mm vs. 6 mm)CompletedNCT00343343Phase 2
- Family Investigation of Nephropathy and Diabetes (F.I.N.D.)Active, not recruitingNCT00342927
- Exercise Training in Older Diabetic WomenCompletedNCT00341614Phase 1
- Cross-Sectional and Longitudinal Studies of "Pre-Diabetes" in the Pima IndiansCompletedNCT00340132
- Prospective Studies of the Natural History of Diabetes Mellitus and Its Complications in the Gila River Indian CommunityCompletedNCT00339482
- Endothelial Function as a Marker for Blood Pressure Control Among Hypertensive Diabetic PatientsCompletedNCT00337038Early Phase 1
- A Double-Blind, Randomized, Parallel, Comparative Study to Evaluate the Efficacy and Safety of an Antidiabetic Agent Repaglinide for the Treatment of Type 2 Diabetes Mellitus PatientsStatus unknownNCT00336310Phase 4
- Pilot Study of ONO-5129 in Patients With Type 2 Diabetes MellitusCompletedNCT00335712Phase 2
- Lantus Effect on Myocardial Glucose Metabolism in T2CompletedNCT00335465Phase 4
- RCT of the Naturopathic Anti-Inflammatory DietCompletedNCT00334919Phase 2
- Open Trial of Miglitol in Type 2 Diabetic Patients Treated With BiguanideCompletedNCT00334503Phase 3
- Double-Blind Trial of Miglitol in Type 2 Diabetic Patients Treated With BiguanideCompletedNCT00334399Phase 3
- AVANDIA With Glyburide In African American And Hispanic Patients With Type 2 Diabetes Not Controlled by Glyburide AloneCompletedNCT00333723Phase 4
- Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00333151Phase 3